TQ4-59142-95263
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 076 / NJ
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-01
Dose 1 — Pfizer-BioNTech
-
2021-02-02
Registered in v-safe
- 2021-02-02
-
2021-02-03
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis — Feeling: Fair · Site: Redness · Fatigue or tiredness, Abdominal painFree text: Intermittent sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-10
- 2021-02-15
- 2021-02-24
-
2021-02-25
Dose 2 — Pfizer-BioNTech
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
- 2021-03-25
- 2021-04-08
- 2021-08-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Intermittent sweats
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release